Epoch Investment Partners Inc. Has $203 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Epoch Investment Partners Inc. lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 16.4% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 631,854 shares of the company’s stock after purchasing an additional 88,948 shares during the period. HCA Healthcare accounts for approximately 0.9% of Epoch Investment Partners Inc.’s holdings, making the stock its 21st largest holding. Epoch Investment Partners Inc.’s holdings in HCA Healthcare were worth $203,002,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Bangor Savings Bank raised its stake in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $28,000. GPS Wealth Strategies Group LLC lifted its stake in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. acquired a new stake in shares of HCA Healthcare during the first quarter worth $33,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research reports. UBS Group increased their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Truist Financial boosted their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Barclays lifted their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Finally, Oppenheimer increased their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Stock Up 0.3 %

HCA Healthcare stock opened at $404.66 on Friday. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $405.70. The stock has a market cap of $105.99 billion, a P/E ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67. The company’s 50-day moving average price is $370.57 and its two-hundred day moving average price is $340.65. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm posted $4.29 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock valued at $6,407,273 over the last 90 days. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.